Arsenic trioxide causes redistribution of cell cycle, caspase activation, and GADD expression in human colonic, breast, and pancreatic cancer cells.

Abstract:

:Arsenic trioxide is valuable for treatment of promyelocytic leukemia, but less attention has been paid to its therapeutic potential for other cancers. In this study, the effects of arsenic trioxide were tested in human pancreatic (AsPC-1), colonic (HT-29), and breast (MCF-7) cancer cells. In all three cancer cell lines, arsenic trioxide inhibited proliferation in a concentration and time-dependent manner, as measured by 3H-methyl thymidine incorporation and cell counting. Coincident with inhibition of growth, arsenic trioxide induced marked morphologic changes, including reduced cytoplasmic volume, membrane blebbing, and nuclear condensation consistent with apoptosis. Propidium iodide DNA staining at 24 hours revealed cell cycle arrest in the G0/G1 phase and an increase in the S phase, while at 72 hr there was G2/M phase arrest with a marked increase in the sub-G0/G1, apoptotic cell population. The DNA fragmentation induced by arsenic trioxide was confirmed by the terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling (TUNEL) assay in all cell lines. Western blot analysis revealed activation of caspase -3, -7, and -9 by arsenic trioxide. Caspase-3 activity was confirmed by demonstrating cleavage of its downstream target, poly ADP-ribose polymerase (PARP). Expression of the antiapoptosis protein, Bcl-2, was time-dependently decreased. In contrast, arsenic trioxide markedly enhanced the expression of the p21 protein, GADD45 and GADD153, in a time-dependent manner. These findings suggest that arsenic trioxide has potential as a therapeutic agent for these cancers.

journal_name

Cancer Invest

journal_title

Cancer investigation

authors

Li X,Ding X,Adrian TE

doi

10.1081/cnv-200029068

subject

Has Abstract

pub_date

2004-01-01 00:00:00

pages

389-400

issue

3

eissn

0735-7907

issn

1532-4192

journal_volume

22

pub_type

杂志文章
  • Doxorubicin and paclitaxel in the treatment of advanced breast cancer: efficacy and cardiac considerations.

    abstract::Doxorubicin and paclitaxel are highly active agents in the treatment of advanced breast cancer. Although early trials of the combination reported high response rates, an unexpectedly high incidence of congestive heart failure observed on two of the early trials was cause for much concern. More recently, clinical trial...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1081/cnv-100000150

    authors: Perez EA

    更新日期:2001-01-01 00:00:00

  • Low energy proton beam induces efficient cell killing in A549 lung adenocarcinoma cells.

    abstract::The aim of the current study was to determine the signaling differences between gamma- and proton beam-irradiations. A549 lung adenocarcinoma cells were irradiated with 2 Gy proton beam or gamma-radiation. Proton beam was found to be more cytotoxic than gamma-radiation. Proton beam-irradiated cells showed phosphorylat...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357901003630991

    authors: Ghosh S,Bhat NN,Santra S,Thomas RG,Gupta SK,Choudhury RK,Krishna M

    更新日期:2010-07-01 00:00:00

  • ErbB receptors as prognostic and therapeutic drug targets in bone and soft tissue sarcomas.

    abstract::ErbB receptors have been intensely studied to understand their importance in cancer biology and as therapeutic targets, and many ErbB inhibitors are now used in the clinical setting. A large number of studies have been conducted to examine the expression of ErbB family members in bone and soft tissue sarcomas, includi...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357907.2014.964409

    authors: Wang H,Yang Q,Fu Z,Zuo D,Hua Y,Cai Z

    更新日期:2014-12-01 00:00:00

  • Manganese superoxide dismutase expression as a function of genotype and lung cancer pathology.

    abstract:INTRODUCTION:The aim of this study was to compare the manganese superoxide dismutase (MnSOD) expression in matched tumor and normal tissue. METHODS:One hundred lung cancer specimens and matched normal lung parenchyma from the same patient were evaluated for MnSOD expression. RESULTS:The median normal MnSOD expression...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357900903405918

    authors: Martin RC,Li Y,Liu Q,Barker DF,Doll MA,Hein DW

    更新日期:2010-10-01 00:00:00

  • Association between methylation of SHP-1 isoform I and SSTR2A promoter regions with breast and prostate carcinoma development.

    abstract::Methylation pattern is presented here for first time as a potential molecular marker of changes on SSTR2A and SHP-1(I) gene promoter related to breast and prostate carcinoma. Our results have shown low concordances with SSTR2A and methylated state in prostate cancer and moderate relationship with unmethylated CpG-27 i...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2014.1001892

    authors: Tiscornia MM,González HS,Lorenzati MA,Zapata PD

    更新日期:2015-03-01 00:00:00

  • Phase II trial of ifosfamide, fluorouracil, and folinic acid (FIFO regimen) in relapsed and refractory urothelial cancer.

    abstract::There is no known effective salvage chemotherapy for patients with refractory or relapsed urothelial tumors after methotrexate/cisplatin-based regimen. We report the results of a phase II trial with the FIFO regimen that includes from day 1 to 5: fluorouracil 350 mg/m2, folinic acid 20 mg/m2, and ifosfamide 1000 mg/m2...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章

    doi:10.3109/07357909509094462

    authors: Kattan J,Culine S,Theodore C,Droz JP

    更新日期:1995-01-01 00:00:00

  • Intensity modulated arc therapy in bilaterally irradiated head and neck cancer: a comparative and prospective multicenter planning study.

    abstract::A dosimetric comparison was made of Helical Tomotherapy (HT) and Rapid'Arc(®) (RA) in 115 patients with head and neck carcinoma included in a prospective and multicentric study. HT and RA provided highly conformal plans that easily complied with dose volume constraints for organs at risk. HT reduced high doses to the ...

    journal_title:Cancer investigation

    pub_type: 杂志文章,多中心研究

    doi:10.3109/07357907.2014.889705

    authors: Vernat SS,Ali D,Messina C,Pommier P,Dussart S,Puyraveau M,Viard R,Lacornerie T,Lisbona A,Fenoglietto P,Mazurier J,Garcia R,Hangard G,Zefkili S,Makovicka L,Giraud P

    更新日期:2014-06-01 00:00:00

  • Does routine clinical practice reproduce the outcome of large prospective trials? The analysis of institutional database on patients with limited-disease small-cell lung cancer.

    abstract::We performed the analysis of database on 409 patients with LD-SCLC to evaluate as to what extent the clinical outcome of large prospective trials was reproduced in routine practice. The analysis has shown that the hazard rate of death in the absence of prophylactic cranial irradiation (PCI) adjusted for the effects of...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2013.861470

    authors: Wzietek I,Suwinski R,Nowara E,Bialas M,Bentzen S,Tukiendorf A

    更新日期:2014-01-01 00:00:00

  • Ab initio studies of some amino acid residue complexes with 4-mercaptopyridine as a model for thymitaq (AG337), an inhibitor of thymidylate synthase.

    abstract::The complex formed by isopentane, as a model for the isoleucine residue present in the wild-type thymidylate synthase, with 4-mercaptopyridine as a fragment of the thymidylate synthase inhibitor Thymitaq (AG337) is investigated with ab initio quantum chemical calculations at Hartree-Fock and MP2 levels, using the 3-21...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909909021431

    authors: Sapse DS,Tong Y,Bertino JR,Sapse AM

    更新日期:1999-01-01 00:00:00

  • Radiation recall dermatitis induced by edatrexate in a patient with breast cancer.

    abstract::Enhancement of radiation injury to the skin and mucous membranes has been observed with a number of chemotherapeutic agents. A 32-year-old woman with metastatic breast cancer received local radiation therapy to the lumbosacral area. Six weeks later, systemic edatrexate therapy was initiated and a localized painful ery...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909509024929

    authors: Perez EA,Campbell DL,Ryu JK

    更新日期:1995-01-01 00:00:00

  • A phase I trial of chlorambucil administered in short pulses in patients with advanced malignancies.

    abstract::We carried out a phase I trial with chlorambucil. Thirty patients with advanced cancer were entered in six dose levels: 36, 48, 60, 84, 108, and 144 mg/m2. The drug was given in six divided oral doses every 6 hours and the regimen was repeated every 3 weeks. The median age was 62 years (31-84), median Karnofsky perfor...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908809080064

    authors: Blumenreich MS,Woodcock TM,Sherrill EJ,Richman SP,Gentile PS,Epremian BE,Kubota TT,Allegra JC

    更新日期:1988-01-01 00:00:00

  • Nerve growth factor receptor immunoreactivity in breast cancer patients.

    abstract::Nerve growth factor receptor (NGF-R) has been shown to have antiproliferative, differentiative, or apoptotic effects on some types of tumor cells, whereas in others it may have mitogenic activity. The immunohistochemical distribution of NGF-R was analyzed in a series of tissue samples from breast cancer patients and i...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1081/cnv-100106144

    authors: Aragona M,Panetta S,Silipigni AM,Romeo DL,Pastura G,Mesiti M,Cascinu S,La Torre F

    更新日期:2001-01-01 00:00:00

  • Chemiluminescence production by neutrophils and immune complex levels in cancer patients.

    abstract::We studied the production of chemiluminescence (CL) by peripheral blood neutrophils from 24 normal subjects, 13 lung cancer patients with clinical stages (CS) III and IV, and 27 breast cancer patients with CS II, III, and IV. Evaluations were made before chemo- and radiotherapy treatments. CL was expressed as: baselin...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909309011669

    authors: Chasseing NA,Barañao RI,Fernández O,Bordenave H,Rumi LS

    更新日期:1993-01-01 00:00:00

  • Association of genetic polymorphisms of N-acetyltransferase 2 and susceptibility to esophageal cancer in north Indian population.

    abstract::Esophageal cancer is multifactorial disease involving environmental and genetic risk factors. Tobacco smoke and alcohol are strong environmental risk factors. N-acetyltransferase 2 (NAT2) is known to metabolize heterocyclic amine carcinogens in tobacco smoke. The purpose of this study was to determine whether genetic ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900701358074

    authors: Jain M,Kumar S,Lal P,Tiwari A,Ghoshal UC,Mittal B

    更新日期:2007-08-01 00:00:00

  • Emotional Response of US Breast Cancer Survivors during the COVID-19 Pandemic.

    abstract::In a sample of 633 US adult breast cancer survivors, we examined health-related worry as a function vulnerability as influenced by communication, trust, and planning with their cancer care team during the COVID-19 pandemic. We found significant positive correlations between communication and trust, communication and p...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2020.1841220

    authors: Papautsky EL,Hamlish T

    更新日期:2021-01-01 00:00:00

  • Stereotactic Body Radiation Therapy (SBRT) in Pelvic Lymph Node Oligometastases.

    abstract::The role of stereotactic body radiation therapy (SBRT) in achieving durable local control and palliation of pain in pelvic lymph node oligometastatic disease is not well-studied. We performed a retrospective analysis of 30 patients with 43 pelvic lymph node oligometastases from various primary cancers all but one with...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2020.1801713

    authors: Reshko LB,Richardson MK,Spencer K,Kersh CR

    更新日期:2020-11-01 00:00:00

  • Study of the natural history of immunoblastic lymphadenopathy and atypical immunoproliferative disorders.

    abstract::Twenty-three patients, 9 with immunoblastic lymphadenopathy and 14 with atypical immunoproliferative disorders (AIPD), were studied in order to determine their clinical, radiographic, and pathologic features. Diffuse lymphadenopathy was present in all patients. Patients with immunoblastic lymphadenopathy (ILA) had an ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908309063292

    authors: Lopez-Berestein G,Cabanillas F,Osborne BM,Libshitz HI,Bodey GP

    更新日期:1983-01-01 00:00:00

  • Utility of gene promoter methylation in prediction of response to platinum-based chemotherapy in epithelial ovarian cancer (EOC).

    abstract::The aim was to determine whether promoter methylation of BRCA1, MGMT, MLH1, RASSF1A, and p16 genes could predict response to platinum-based chemotherapy. Thirty-five subjects with epithelial ovarian cancer (EOC) treated by platinum-based chemotherapy were recruited. Methylation-specific polymerase chain reaction was c...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900902849699

    authors: Chaudhry P,Srinivasan R,Patel FD

    更新日期:2009-10-01 00:00:00

  • Inhibition of tumor progression and paraneoplastic syndrome development in a murine lung adenocarcinoma by medroxyprogesterone acetate and indomethacin.

    abstract::Mice bearing LP07 lung adenocarcinoma present some characteristics similar to those shown in patients with several malignant diseases. LP07 tumor bearers develop paraneoplastic syndromes such as cachexia, leukocytosis, and hypercalcemia, partly due to a systemic inflammatory response. We analyzed some of the mechanism...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900500524322

    authors: Diament MJ,Peluffo GD,Stillitani I,Cerchietti LC,Navigante A,Ranuncolo SM,Klein SM

    更新日期:2006-03-01 00:00:00

  • UFT and oral leucovorin as radiation sensitizers in rectal and other gastrointestinal malignancies.

    abstract::UFT is the combination of the fluorouracil (5-FU) prodrug tegafur, and the dihydrophyrimidine dehydrogenase inhibitor uracil. UFT and leucovorin have been used in the oral treatment of a variety of malignancies. Given the radiosensitizing properties of UFT, its combination with radiation therapy is a logical step in t...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1081/cnv-120022382

    authors: Saad ED,Hoff PM

    更新日期:2003-01-01 00:00:00

  • Gene expression profile associated with oncogenic ras-induced senescence, cell death, and transforming properties in human cells.

    abstract::We developed inducible and constitutive expression systems of Ha-RasV12 in HEK 293 cells to examine early oncogenic RasV12 signaling. Inducible expression of oncogenic Ras-triggered growth arrest, early senescence, and later apoptosis. Gene expression profile analysis revealed early Ras proliferation and cell cycle ge...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357900903095623

    authors: Moumtzi SS,Roberts ML,Joyce T,Evangelidou M,Probert L,Frillingos S,Fotsis T,Pintzas A

    更新日期:2010-07-01 00:00:00

  • Conventional versus high-dose epidoxorubicin as single agent in advanced breast cancer.

    abstract::Between March 1986 and December 1987, two groups of consecutive patients with advanced breast cancer underwent epidoxorubicin (Epidx) monochemotherapy. Twenty-three patients (group A) received Epidx at a dose of 60 mg/m2 and 27 (group B) at a dose of 120 mg/m2 (i.v. every 3 weeks). No patient had undergone anthracycli...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章

    doi:10.3109/07357909309024827

    authors: Neri B,Pacini P,Algeri R,Lottini G,Rinaldini M,Tucci E,Pusterla R

    更新日期:1993-01-01 00:00:00

  • Comparison of serum interleukin-10 (IL-10) levels between normal volunteers and patients with advanced melanoma.

    abstract::Melanoma is an immunoresponsive malignancy. Interleukin-10 (IL-10) is a potent regulator of immunosuppression. The purpose of this research was to define the relationship of serum IL-10 to survival in patients with metastatic melanoma. Forty-one melanoma patients and 50 normal volunteers were analyzed. The median IL-1...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1081/cnv-100102550

    authors: Nemunaitis J,Fong T,Shabe P,Martineau D,Ando D

    更新日期:2001-01-01 00:00:00

  • An analog of withaferin A activates the MAPK and glutathione "stress" pathways and inhibits pancreatic cancer cell proliferation.

    abstract::Withaferin A (WA) (1) and two analogs [4-epi-withaferin A (2) and 4,27-diacetyl-4-epi-withaferin A (3)] were evaluated for antitumor activity in pancreatic cancer cells. IC(50) for 1, 2, and 3 were 0.87, 0.45, and 0.29 ?M (BxPC-3); 1.28, 1.53, and 0.52 ?M (MIAPaCa-2); and 0.59, 2.25, and 0.56 ?M (PANC-1), respectively...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2011.626478

    authors: Liu X,Qi W,Cooke LS,Kithsiri Wijeratne EM,Xu YM,Marron MT,Leslie Gunatilaka AA,Mahadevan D

    更新日期:2011-12-01 00:00:00

  • The role of irreversible EGFR inhibitors in the treatment of non-small cell lung cancer: overcoming resistance to reversible EGFR inhibitors.

    abstract::Reversible epidermal growth factor receptor tyrosine kinase inhibitors are often used for the treatment of non-small cell lung cancer following failure of cytotoxic chemotherapy. While these agents are active in a subset of patients, most develop resistance and progress within the course of 1 year. In nearly half of t...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357901003631072

    authors: Belani CP

    更新日期:2010-05-01 00:00:00

  • A phase I trial to determine the safety of imatinib in combination with vatalanib in patients with advanced malignancies.

    abstract::The role of tyrosine kinase inhibitors (TKIs) in the treatment of advanced malignancies is well established. Imatinib and vatalanib are oral TKIs with different mechanisms of action. This trial sought to establish the safety, tolerability, and maximum tolerated dose (MTD) of the two agents in combination. Secondary ob...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2011.568567

    authors: Spigel D,Jones S,Hainsworth J,Infante J,Greco FA,Thompson D,Doss H,Burris H

    更新日期:2011-05-01 00:00:00

  • Introduction to genetic linkage analysis.

    abstract::Advances in molecular methodology have resulted in the successful genetic mapping and isolation of the genes responsible for numerous simple Mendelian disorders such as cystic fibrosis, neurofibromatosis, and Huntington disease. Recently, researchers have begun to successfully study diseases with more complex inherita...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909709047596

    authors: Foroud T

    更新日期:1997-01-01 00:00:00

  • Possible Role and Therapeutic Target of PDGF-D Signalling in Colorectal Cancer.

    abstract::Platelet-derived growth factor D (PDGF-D) has been shown to mediate cellular processes of importance in cancer progression. This study aimed to investigate the expression and putative involvement of PDGF-D signaling in colorectal carcinogenesis. PDGF-D was expressed in vascular endothelial cells in tumor and normal ti...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2019.1576191

    authors: Olsen RS,Dimberg J,Geffers R,Wågsäter D

    更新日期:2019-01-01 00:00:00

  • Association of polymorphisms in regulatory regions of interleukin-12p40 gene and cytokine serum level with colorectal cancer.

    abstract::The present study investigates the association between IL12Bpro and +16974A/C in 3' -untranslated region (UTR) polymorphisms of IL12B and IL-12p40 serum level related to development of colorectal cancer (CRC). Our results showed similar distribution of both the investigated polymorphisms among CRC patients and healthy...

    journal_title:Cancer investigation

    pub_type: 杂志文章,多中心研究

    doi:10.3109/07357900902918486

    authors: Miteva L,Stanilov N,Deliysky T,Mintchev N,Stanilova S

    更新日期:2009-11-01 00:00:00

  • Lung Cancer in Never-Smoking Women: A Sub-Analysis of the Spanish Female-Specific Database WORLD07.

    abstract::The WORLD07 study characterizes lung cancer in Spanish women. This analysis investigated lung cancer features in never-smoking women. Of 2072 women recruited, 2035 were analyzed. Patient characteristics and demographics were similar for current/former smokers and never smokers. Among never smokers, 38.3% were exposed ...

    journal_title:Cancer investigation

    pub_type: 杂志文章,多中心研究

    doi:10.1080/07357907.2017.1295461

    authors: Viñolas N,Garrido P,Isla D,Provencio M,Majem M,Artal A,Carcereny E,Garcia Campelo R,Lianes P,De La Peñas R,Felip E

    更新日期:2017-05-28 00:00:00